Cancer Screening

Neurofibromatosis type 1, or NF1, is the most common cancer predisposition syndrome

Test can detect over 50 types of cancer, often before symptoms show

Does universal genetic screening of patients with solid tumors improve detection of high-risk variants?

Delayed cancer screening due to COVID-19 could mean more cancer-related deaths for years to come

A new study demonstrates using digital breast tomosynthesis for breast cancer screening has advantages over mammography

Expanded carrier screening relies on high-throughput approaches to catch disease-causing variants that may elude traditional screening

A single test can identify sources of genetic variation underlying inherited colon, endometrial, and other cancers

Although screening can lead to earlier detection, most patients are diagnosed when the cancer is advanced and often incurable

St. Jude researchers look at the combined effect of cancer treatments and inherited mutations in DNA-repair genes

How does your lab perform cancer screening and diagnostic testing?